<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30429970</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>18</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Electronic">2040-2511</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>9</Volume>                    <Issue>10</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>01</Day>                    </PubDate>                </JournalIssue>                <Title>MedChemComm</Title>                <ISOAbbreviation>Medchemcomm</ISOAbbreviation>            </Journal>            <ArticleTitle>Synthesis of dihydronaphthalene analogues inspired by combretastatin A-4 and their biological evaluation as anticancer agents.</ArticleTitle>            <Pagination>                <MedlinePgn>1649-1662</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1039/c8md00322j</ELocationID>            <Abstract>                <AbstractText>The natural products colchicine and combretastatin A-4 (<b>CA4</b>) have provided inspiration for the discovery and development of a wide array of derivatives and analogues that inhibit tubulin polymerization through a binding interaction at the colchicine site on β-tubulin. A water-soluble phosphate prodrug salt of <b>CA4</b> (referred to as <b>CA4P</b>) has demonstrated the ability to selectively damage tumor-associated vasculature and ushered in a new class of developmental anticancer agents known as vascular disrupting agents (VDAs). Through a long-term program of structure activity relationship (SAR) driven inquiry, we discovered that the dihydronaphthalene molecular scaffold provided access to small-molecule inhibitors of tubulin polymerization. In particular, a dihydronaphthalene analogue bearing a pendant trimethoxy aryl ring (referred to as <b>KGP03</b>) and a similar aroyl ring (referred to as <b>KGP413</b>) were potent inhibitors of tubulin polymerization (IC<sub>50</sub> = 1.0 and 1.2 μM, respectively) and displayed low nM cytotoxicity against human cancer cell lines. In order to enhance water-solubility for <i>in vivo</i> evaluation, the corresponding phosphate prodrug salts (<b>KGP04</b> and <b>KGP152</b>, respectively) were synthesized. In a preliminary <i>in vivo</i> study in a SCID-BALB/c mouse model bearing the human breast tumor MDA-MB-231-luc, a 99% reduction in signal was observed with bioluminescence imaging (BLI) 4 h after IP administration of <b>KGP152</b> (200 mg kg<sup>-1</sup>) indicating reduced tumor blood flow. In a separate study, disruption of tumor-associated blood flow in a Fischer rat bearing an A549-luc human lung tumor was observed by color Doppler ultrasound following administration of <b>KGP04</b> (15 mg kg<sup>-1</sup>).</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Maguire</LastName>                    <ForeName>Casey J</ForeName>                    <Initials>CJ</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Chemistry and Biochemistry , Baylor University , One Bear Place #97348 , Waco , TX 76798-7348 , USA . Email: Kevin_Pinney@baylor.edu ; Tel: +(254) 710 4117.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chen</LastName>                    <ForeName>Zhi</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Chemistry and Biochemistry , Baylor University , One Bear Place #97348 , Waco , TX 76798-7348 , USA . Email: Kevin_Pinney@baylor.edu ; Tel: +(254) 710 4117.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mocharla</LastName>                    <ForeName>Vani P</ForeName>                    <Initials>VP</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Chemistry and Biochemistry , Baylor University , One Bear Place #97348 , Waco , TX 76798-7348 , USA . Email: Kevin_Pinney@baylor.edu ; Tel: +(254) 710 4117.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sriram</LastName>                    <ForeName>Madhavi</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Chemistry and Biochemistry , Baylor University , One Bear Place #97348 , Waco , TX 76798-7348 , USA . Email: Kevin_Pinney@baylor.edu ; Tel: +(254) 710 4117.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Strecker</LastName>                    <ForeName>Tracy E</ForeName>                    <Initials>TE</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Chemistry and Biochemistry , Baylor University , One Bear Place #97348 , Waco , TX 76798-7348 , USA . Email: Kevin_Pinney@baylor.edu ; Tel: +(254) 710 4117.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hamel</LastName>                    <ForeName>Ernest</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Screening Technologies Branch , Developmental Therapeutics Program , Division of Cancer Treatment and Diagnosis , National Cancer Institute , Frederick National Laboratory for Cancer Research , National Institutes of Health , Frederick , MD 21702 , USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhou</LastName>                    <ForeName>Heling</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology , The University of Texas Southwestern Medical Center , 5323 Harry Hines Boulevard , Dallas , TX 75390-9058 , USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lopez</LastName>                    <ForeName>Ramona</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology , The University of Texas Southwestern Medical Center , 5323 Harry Hines Boulevard , Dallas , TX 75390-9058 , USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wang</LastName>                    <ForeName>Yifan</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Chemistry and Biochemistry , Baylor University , One Bear Place #97348 , Waco , TX 76798-7348 , USA . Email: Kevin_Pinney@baylor.edu ; Tel: +(254) 710 4117.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mason</LastName>                    <ForeName>Ralph P</ForeName>                    <Initials>RP</Initials>                    <Identifier Source="ORCID">0000-0001-7517-3721</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Radiology , The University of Texas Southwestern Medical Center , 5323 Harry Hines Boulevard , Dallas , TX 75390-9058 , USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chaplin</LastName>                    <ForeName>David J</ForeName>                    <Initials>DJ</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Chemistry and Biochemistry , Baylor University , One Bear Place #97348 , Waco , TX 76798-7348 , USA . Email: Kevin_Pinney@baylor.edu ; Tel: +(254) 710 4117.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Mateon Therapeutics, Inc. , 701 Gateway Boulevard, Suite 210 , South San Francisco , CA 94080 , USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Trawick</LastName>                    <ForeName>Mary Lynn</ForeName>                    <Initials>ML</Initials>                    <Identifier Source="ORCID">0000-0002-3734-7329</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Chemistry and Biochemistry , Baylor University , One Bear Place #97348 , Waco , TX 76798-7348 , USA . Email: Kevin_Pinney@baylor.edu ; Tel: +(254) 710 4117.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pinney</LastName>                    <ForeName>Kevin G</ForeName>                    <Initials>KG</Initials>                    <Identifier Source="ORCID">0000-0003-1262-8631</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Chemistry and Biochemistry , Baylor University , One Bear Place #97348 , Waco , TX 76798-7348 , USA . Email: Kevin_Pinney@baylor.edu ; Tel: +(254) 710 4117.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>24</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Medchemcomm</MedlineTA>            <NlmUniqueID>101531525</NlmUniqueID>            <ISSNLinking>2040-2503</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Bioorg Med Chem. 2013 Dec 15;21(24):8019-32</RefSource>                <PMID Version="1">24183586</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochim Biophys Acta. 1981 Jul;675(2):226-31</RefSource>                <PMID Version="1">6115675</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer Clin Oncol. 1983 Feb;19(2):271-5</RefSource>                <PMID Version="1">6681772</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Nucl Med Mol Imaging. 2015 Jan 15;5(2):143-53</RefSource>                <PMID Version="1">25973335</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):416-20</RefSource>                <PMID Version="1">15701823</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2001 Feb;2(2):82-7</RefSource>                <PMID Version="1">11905799</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Drug Des. 2000 Jun;15(3):203-16</RefSource>                <PMID Version="1">11049088</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 1989 Dec 1;49(23):6449-65</RefSource>                <PMID Version="1">2684393</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Expert Opin Investig Drugs. 2009 Feb;18(2):189-97</RefSource>                <PMID Version="1">19236265</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Nat Prod. 2009 Mar 27;72(3):380-8</RefSource>                <PMID Version="1">19228038</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Medchemcomm. 2012 Jun;3(6):720-724</RefSource>                <PMID Version="1">23772309</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Nat Prod. 1987 Jan-Feb;50(1):119-31</RefSource>                <PMID Version="1">3598594</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Med Chem. 2012 Jun;52:22-32</RefSource>                <PMID Version="1">22449653</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Jun 6;8(23):37464-37477</RefSource>                <PMID Version="1">28415581</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Nat Prod. 2008 Mar;71(3):313-20</RefSource>                <PMID Version="1">18303849</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Endocrinology. 1983 Aug;113(2):611-7</RefSource>                <PMID Version="1">6872943</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Med Chem. 1998 May 7;41(10):1688-95</RefSource>                <PMID Version="1">9572894</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2004 Jun 15;100(12):2491-9</RefSource>                <PMID Version="1">15197790</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Nat Prod. 2009 Mar 27;72(3):414-21</RefSource>                <PMID Version="1">19161336</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Nat Prod. 2013 Sep 27;76(9):1668-78</RefSource>                <PMID Version="1">24016002</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Treat Rev. 2011 Feb;37(1):63-74</RefSource>                <PMID Version="1">20570444</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>FASEB J. 2008 Jul;22(7):2445-51</RefSource>                <PMID Version="1">18263704</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bioorg Med Chem. 2008 Sep 1;16(17):8161-71</RefSource>                <PMID Version="1">18722127</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Medchemcomm. 2016 Dec 1;7(12):2418-2427</RefSource>                <PMID Version="1">28217276</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ultrasound Med Biol. 2018 Apr;44(4):840-852</RefSource>                <PMID Version="1">29395676</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bioorg Med Chem. 2015 Dec 15;23(24):7497-520</RefSource>                <PMID Version="1">26775540</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2016 Mar 29;7(13):15444-59</RefSource>                <PMID Version="1">26812886</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Pharm Des. 2005;11(13):1655-77</RefSource>                <PMID Version="1">15892667</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2005 Jun;5(6):423-35</RefSource>                <PMID Version="1">15928673</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 1991 Jun 5;83(11):757-66</RefSource>                <PMID Version="1">2041050</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Steroids. 1992 May;57(5):222-32</RefSource>                <PMID Version="1">1488784</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bioorg Med Chem. 2009 Oct 1;17(19):6993-7001</RefSource>                <PMID Version="1">19733085</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Integr Biol (Camb). 2011 Apr;3(4):375-87</RefSource>                <PMID Version="1">21321746</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochem Biophys Res Commun. 2005 Jul 29;333(2):328-35</RefSource>                <PMID Version="1">15961063</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Biochem Biophys. 2003;38(1):1-22</RefSource>                <PMID Version="1">12663938</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Nat Prod. 2011 Jul 22;74(7):1568-74</RefSource>                <PMID Version="1">21718055</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Hyperthermia. 2008 Feb;24(1):57-65</RefSource>                <PMID Version="1">18214769</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Org Chem. 2007 Feb 16;72(4):1507-9</RefSource>                <PMID Version="1">17253749</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Res Rev. 2011 May;31(3):443-81</RefSource>                <PMID Version="1">21381049</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Exp Pathol. 2002 Feb;83(1):21-38</RefSource>                <PMID Version="1">12059907</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Lett. 2015 Dec 1;369(1):229-41</RefSource>                <PMID Version="1">26325604</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bioorg Chem. 2017 Jun;72:130-147</RefSource>                <PMID Version="1">28460355</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Invest. 2017 Sep 14;35(8):519-534</RefSource>                <PMID Version="1">28872367</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Med Chem. 1995 May 12;38(10):1666-72</RefSource>                <PMID Version="1">7752190</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2001 Sep 1;61(17):6413-22</RefSource>                <PMID Version="1">11522635</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bioorg Med Chem. 2016 Mar 1;24(5):938-956</RefSource>                <PMID Version="1">26852340</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Protoc. 2006;1(3):1112-6</RefSource>                <PMID Version="1">17406391</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Tetrahedron Lett. 2015 Jun 3;56(23):3624-3629</RefSource>                <PMID Version="1">26973358</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2004 Jan 15;10(2):415-27</RefSource>                <PMID Version="1">14760060</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2012;7(8):e43314</RefSource>                <PMID Version="1">22937031</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cytotechnology. 1998 Sep;27(1-3):249-56</RefSource>                <PMID Version="1">19002796</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Exp Oncol. 2010 Sep;32(3):143-8</RefSource>                <PMID Version="1">21403608</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Med Chem. 2000 Jul 13;43(14):2731-7</RefSource>                <PMID Version="1">10893310</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Imaging Biol. 2016 Dec;18(6):860-869</RefSource>                <PMID Version="1">27160251</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Experientia. 1989 Feb 15;45(2):209-11</RefSource>                <PMID Version="1">2920809</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Exp Pathol. 2009 Jun;90(3):284-94</RefSource>                <PMID Version="1">19563611</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Drug Des. 1998 Apr;13(3):183-91</RefSource>                <PMID Version="1">9595032</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2012;7(9):e46106</RefSource>                <PMID Version="1">23029403</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Med Chem. 2006 Jun 1;49(11):3033-44</RefSource>                <PMID Version="1">16722619</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bioorg Med Chem Lett. 1999 Apr 19;9(8):1081-6</RefSource>                <PMID Version="1">10328289</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Pharm Des. 2013;19(10):1923-55</RefSource>                <PMID Version="1">23237054</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>06</Month>                <Day>28</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>13</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pmc-release">                <Year>2019</Year>                <Month>08</Month>                <Day>24</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>16</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>11</Month>                <Day>16</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>16</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30429970</ArticleId>            <ArticleId IdType="doi">10.1039/c8md00322j</ArticleId>            <ArticleId IdType="pii">c8md00322j</ArticleId>            <ArticleId IdType="pmc">PMC6201230</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>